跳至主要内容
临床试验/NCT06535945
NCT06535945招募中4 期

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Rennes University Hospital16 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年3月26日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
400
试验地点
16
主要终点
Acute Kindey Injury at Day 7

研究概览

简要总结

To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects equal or above 18 yrs old.
  • Recipients of primary liver allografts from a deceased donor (including after cardiac death) and as a single organ (liver only).
  • Capability of understanding the purpose and risks of the study.
  • Written informed consent

排除标准

  • Fulminant hepatitis
  • Kidney injury at baseline (Estimated Glomerular Filtration Rate < 50 ml/min in Modification of diet in renal disease-6) including hepatorenal syndrome
  • Use of an induction agent Basiliximab at liver transplantation
  • Protected person (adults legally protected, under judicial protection, guardianship, or supervision), person deprived of their liberty

研究组 & 干预措施

30 g/L or below

Experimental

Receive Human Albumin 20% Solution when albumin serum concentration is at 30 g/L or below

干预措施: Albumin administration (Drug)

20 g/L or below

Active Comparator

receive Human Albumin 20% Solution when albumin serum concentration is at 20 g/L or below

干预措施: Albumin administration (Drug)

结局指标

主要结局

Acute Kindey Injury at Day 7

时间窗: 7 days after liver transplantation

To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (=30 g/L) for five days diminishes rate of Acute Kindey Injury at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).

次要结局

  • Occurrence and Severity of each Acute Kindey Injury during the first 7 days after liver transplantation(7 days after liver transplantation)
  • occurrence of acute graft rejection(28 days)
  • hospital length of stay(28 days)
  • occurence of calcineurin inhibitor withdraw(28 days)
  • occurrence of postoperative infections(28 days)
  • occurrence of calcineurin inhibitor induced neurotoxicity(28 days)
  • occurrence of early graft dysfunction(28 days)
  • duration of mechanical ventilation(28 days)
  • reintubation rate(28 days)
  • All cause mortality(28 days)
  • Intensive Care Unit length of stay(28 days)
  • Intensive Care Unit readmission rate(28 days)

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验